XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.23.3

Stock-based Compensation | 3 Months Ended
--- | ---
Sep. 30, 2023
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock-based Compensation |
Note 3: | Stock-based Compensation
In connection with the conversion to stock form, the Association established an ESOP for the exclusive benefit of eligible employees (all salaried employees who have completed at least 1,000 hours of service in a twelve-month period and have attained the age of 21). The ESOP borrowed funds from the Company in an amount sufficient to purchase 384,900 shares (approximately 8% of the Company’s common stock issued in the stock offering). The loan is secured by the shares purchased and will be repaid by the ESOP with funds from contributions made by the Association and dividends received by the ESOP, with funds from any contributions on ESOP assets. Contributions will be applied to repay interest on the loan first, and then the remainder will be applied to principal. The loan is expected to be repaid over a period of up to 20 years. Shares purchased with the loan proceeds are held in a suspense account for allocation among participants as the loan is repaid. Contributions to the ESOP and shares released from the suspense account are allocated among participants in proportion to their compensation, relative to total compensation of all active participants. Participants will vest 100% in their accrued benefits under the employee stock ownership plan after six vesting years, with prorated vesting in years two through five. Vesting is accelerated upon retirement, death or disability of the participant or a change in control of the Association. Forfeitures will be reallocated to remaining plan participants. Benefits may be payable upon retirement, death, disability, separation from service, or termination of the ESOP. Since the Association’s annual contributions are discretionary, benefits payable under the ESOP cannot be estimated. Participants receive the shares at the end of employment. The Company is accounting for its ESOP in accordance with ASC Topic 718, Employers Accounting for Employee Stock Ownership Plans . Accordingly, the debt of the ESOP is eliminated in consolidation and the shares pledged as collateral are reported as unearned ESOP shares in the consolidated balance sheets. Contributions to the ESOP shall be sufficient to pay principal and interest currently due under the loan agreement. As shares are committed to be released from collateral, the Company reports compensation expense equal to the average market price of the shares for the respective period, and the shares become outstanding for earnings per share computations. Dividends, if any, on unallocated ESOP shares are recorded as a reduction of debt and accrued interest. A summary of ESOP shares at September 30, 2023 and June 30, 2023 are as follows (dollars in thousands):
|  | September 30, 2023 |  |  | June 30, 2023 |
Allocated shares |  |  | 182,231 |  |  |  | 162,986 |
Shares committed for release |  |  | 4,811 |  |  |  | 19,245 |
Unearned shares |  |  | 149,149 |  |  |  | 153,960 |
Total ESOP shares |  |  | 336,191 |  |  |  | 336,191 |
Fair value of unearned ESOP shares (1) |  | $ | 2,221 |  |  | $ | 2,223 |
(1) | Based on closing price of $14.89 and $14.44 per share on September 30, 2023, and June 30, 2023, respectively.
During the three months ended September 30, 2023 and 2022, no ESOP shares were paid to ESOP participants due to separation from service. The IF Bancorp, Inc. 2012 Equity Incentive Plan (the “Equity Incentive Plan”) was approved by stockholders in 2012 for a ten-year period which ended in November 2022. The purpose of the Equity Incentive Plan was to promote the long-term financial success of the Company and its Subsidiaries by providing a means to attract, retain and reward individuals who contribute to such success and to further align their interests with those of the Company’s stockholders. The Equity Incentive Plan authorized the issuance or delivery to participants of up to 673,575 shares of the Company common stock pursuant to grants of incentive and non-qualified stock options, restricted stock awards and restricted stock unit awards, provided that the maximum number of shares of Company common stock that may be delivered pursuant to the exercise of stock options (all of which may be granted as incentive stock options) was 481,125 and the maximum number of shares of Company stock that may be issued as restricted stock awards or restricted stock units was 192,450. This plan was replaced by the 2022 Equity Incentive Plan when the stockholders approved the new plan on November 21, 2022. The new plan authorizes the issuance or delivery to participants of up to 264,850 shares of the Company common stock pursuant to grants of incentive and non-qualified stock options, restricted stock awards and restricted stock unit awards, provided that the maximum number of shares of Company common stock that may be delivered pursuant to the exercise of stock options (all of which may be granted as incentive stock options) was 52,970 and the maximum number of shares of Company stock that may be issued as restricted stock awards or restricted stock units was 211,880. On December 10, 2013, 85,500 shares of restricted stock and 167,000 in stock options were awarded to senior officers and directors of the Association. These shares of restricted stock vest in equal installments over 10 years and the stock options vested in equal installments over 7 years. Vesting of both the restricted stock and options started in December 2014. On December 10, 2015, 16,900 shares of restricted stock were awarded to senior officers and directors of the Association. These shares of restricted stock vest in equal installments over 8 years, starting in December 2016. On September 9, 2022, 53,000 shares of restricted stock were awarded to senior officers and directors of the Association. These shares of restricted stock will vest in equal installments over 5 years, starting in September 2023. No shares have been granted from the 2022 Equity Incentive Plan as of September 30, 2023, so there are 211,880 shares of restricted stock and 52,970 stock option shares available for future grants under this plan. The following table summarizes stock option activity for the three months ended September 30, 2023 (dollars in thousands):
|  | Options |  |  | Weighted-Average Exercise Price/Share |  |  | Weighted-Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value |
Outstanding, June 30, 2023 |  |  | 90,143 |  |  | $ | 16.63 |  |  |  |  |  |  |  |  |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Outstanding, September 30, 2023 |  |  | 90,143 |  |  | $ | 16.63 |  |  |  | 0.2 |  |  | $ | — | (1)
Exercisable, September 30, 2023 |  |  | 90,143 |  |  | $ | 16.63 |  |  |  | 0.2 |  |  | $ | — | (1)
(1) | Based on closing price of $14.89 per share on September 30, 2023.
Intrinsic value for stock options is defined as the difference between the current market value and the exercise price. There were no stock options granted during the three months ended September 30, 2023. No stock options vested during the three months ended September 30, 2023 and 2022. Stock-based compensation expense and related tax benefit were zero for stock options for the three months ended September 30, 2023 and 2022. Compensation costs related to non-vested stock options were recognized over a seven-year vesting period that ended in December, 2020, leaving no unrecognized compensation cost at September 30, 2023. The following table summarizes non-vested restricted stock activity for the three months ended September 30, 2023:
|  | Shares |  |  | Weighted-Average Grant- Date Fair Value |
Balance, June 30, 2023 |  |  | 62,314 |  |  | $ | 18.76 |
Granted |  |  | — |  |  |  | — |
Forfeited |  |  | — |  |  |  | — |
Earned and issued |  |  | 10,600 |  |  |  | 19.10 |
Balance, September 30, 2023 |  |  | 51,714 |  |  | $ | 18.69 |
The fair value of the restricted stock awards is amortized to compensation expense over the vesting period and is based on the market price of the Company’s common stock at the date of grant multiplied by the number of shares granted that are expected to vest. At the date of grant the par value of the shares granted was recorded in equity as a credit to common stock and a debit to paid-in capital. Stock-based compensation expense and related tax benefit for restricted stock, which was recognized in non-interest expense, was $90,000 and $26,000, respectively, for the three months ended September 30, 2023, and was $56,000 and $16,000, respectively, for the three months ended September 30, 2022. Unrecognized compensation expense for non-vested restricted stock awards was $833,000 and is expected to be recognized over 3.9 years with a corresponding credit to paid-in capital.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration